Abnova Taiwan logo

4133 - Abnova Taiwan Share Price

TWD67.7 6.1  9.9%

Last Trade - 22/05/20

Small Cap
Market Cap £112.1m
Enterprise Value £108.0m
Revenue £11.3m
Position in Universe 2548th / 5948
Unlock 4133 Revenue
Relative Strength (%)
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Financial Summary
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2019, Abnova (Taiwan) Corporation. revenues decreased 3% to NT$414.2M. Net income decreased 93% to NT$3.3M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income also reflects Expected Credit Gain/Loss increase from NT$1.5M to NT$27.2M (expense), Miscellaneous Income decrease of 84% to NT$1.3M (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


4133 Revenue Unlock 4133 Revenue

Net Income

4133 Net Income Unlock 4133 Revenue

Normalised EPS

4133 Normalised EPS Unlock 4133 Revenue

PE Ratio Range

4133 PE Ratio Range Unlock 4133 Revenue

Dividend Yield Range

4133 Dividend Yield Range Unlock 4133 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
4133 EPS Forecasts Unlock 4133 Revenue
Profile Summary

ABNOVA (TAIWAN) CORPORATION is a Taiwan-based company principally engaged in the manufacturing and sales of antibodies and proteins. The Company's products mainly include monoclonal antibodies, polyclonal antibodies, protein fragments, full-length proteins, active proteins, antibody pairs, fluorescence in situ hybridization probe and others. The Company's monoclonal and polyclonal antibodies are primarily applied in medical testing reagents, agricultural testing, industrial purification, medical treatment and other fields. Its proteins are mainly applied in medical testing reagents, agricultural testing, medical treatment, protein engineering and other fields. Its products are mainly traded in Taiwan, Americas and Europe.

Last Annual December 31st, 2019
Last Interim December 31st, 2019
Incorporated January 4, 2002
Public Since May 27, 2008
No. of Shareholders: n/a
No. of Employees: 190
Sector Healthcare
Industry Biotechnology & Medical Research
Index Taiwan SE Weighted ,
Exchange Taiwan Stock Exchange
Shares in Issue 60,554,000
Free Float (0.0%)
Eligible for
4133 Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for 4133
Upcoming Events for 4133
Thursday 25th June, 2020 Estimate
Abnova Taiwan Corp Annual Shareholders Meeting
Similar to 4133
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.